Authors:
Perri, F
Villani, MR
Festa, V
Quitadamo, M
Andriulli, A
Citation: F. Perri et al., Predictors of failure of Helicobacter pylori eradication with the standard'Maastricht triple therapy', ALIM PHARM, 15(7), 2001, pp. 1023-1029
Authors:
Andriulli, A
Festa, V
Leandro, G
Rizzetto, M
Citation: A. Andriulli et al., Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection - An AIGO study, DIG DIS SCI, 46(7), 2001, pp. 1409-1415
Authors:
Perri, F
Festa, V
Clemente, R
Villani, MR
Quitadamo, M
Caruso, N
Li Bergoli, M
Andriulli, A
Citation: F. Perri et al., Randomized study of two "rescue" therapies for Helicobacter pylori-infected patients after failure of standard triple therapies, AM J GASTRO, 96(1), 2001, pp. 58-62
Authors:
Perri, F
Festa, V
Clemente, R
Quitadamo, M
Andriulli, A
Citation: F. Perri et al., Rifabutin-based 'rescue therapy' for Helicobacter pylori infected patientsafter failure of standard regimens, ALIM PHARM, 14(3), 2000, pp. 311-316
Authors:
Perri, F
Clemente, R
Festa, V
De Ambrosio, CC
Quitadamo, M
Fusillo, M
Grossi, E
Andriulli, A
Citation: F. Perri et al., Serum tumour necrosis factor-alpha is increased in patients with Helicobacter pylori infection and CagA antibodies, ITAL J GAST, 31(4), 1999, pp. 290-294